A study led jointly by the University of Leeds and Macquarie University in Australia showed how the superbug Acinetobacter baumannii-prevalent among soldiers treated in medical facilities in Iraq and Afghanistan-can pump the disinfectant out of its system.
The findings are critical for the design of new chemicals to combat the germ.
Professor Peter Henderson of the University of Leeds' School of Biomedical Sciences said: "The Australians saw that, in response to chlorhexidine, a gene becomes active and produces a protein they called Acinetobacter Chlorhexidine Efflux, or 'Ace' for short. Working together, we demonstrated that Ace binds to the disinfectant and effectively pumps the chlorhexidine that has leaked through the cell wall out again."
Acinetobacter baumannii was once treatable with normal antibiotics but is now one of the most worrying superbugs threatening the medical system. It has been particularly associated with infections of military personnel injured in Iraq and Afghanistan. Its ability to survive on disinfected artificial surfaces for long periods has allowed it to thrive and spread through the military and into the civilian medical system.
Sally Davies, the Chief Medical Officer for England, said in March that antibiotic resistance posed a "catastrophic threat" that could mean that even minor surgeries might carry deadly risks by the 2030s.
Professor Henderson said: "Identifying the resistance protein now allows us to look for a compound that will inhibit the protein's activity and form the basis of a new treatment against infection."
The early indications are that the protein specifically binds with chlorhexidine rather than other antibiotic molecules. Although some multi-drug resistant proteins have been found, the fight against superbugs has generally been characterised by a painstaking search for several proteins associated with resistance to particular drugs and chemicals.
Members of the University of Leeds' Astbury Centre for Structural Molecular Biology are at the forefront of work on "pump" proteins.
Professor Henderson said: "There are very similar genes in other pathogenic organisms. Our next step will be to explore what these proteins do in those other organisms. In some cases, it is strongly suggested that they make the germ resistant to chlorhexidine, but in others it appears to be something else. We need to find out what that is."
He added: "The bad news is that the bugs are winning. We can't devise new antibiotics nearly fast enough to find a new way of dealing with them and there is not enough funding to pursue the research. This project is typical of the sort of work that we have to do to win the fight against superbugs."
Professor Ian Paulsen at Macquarie University said: "Antiseptics and disinfectants are a key defence used to control the spread of these bacteria in hospitals particularly. Following this discovery, we plan to investigate ways to block this pump. Such work is important in ensuring that we can continue to use successfully this disinfectant to reduce rates of infection in hospitals."
The research is published in the journal Proceedings of the National Academy of Sciences. The work was funded under a European International Research Staff Exchange Scheme (IRSES) project involving the University of Oslo, University of Leeds and Macquarie University. Researchers from Flinders University, Australia also contributed to the research.
Ioannis Delis, Physiological Society (Jul 2018), £10,000
Scott Bowen, Physiological Society (Jul 2018), £10,000
Steve Clapcote, Jamie Johnston, The Dunhill Medical Trust (Jun 2018), £254,874
Adrian Goldman, MRC (Jun 2018), £98,627
Darren Tomlinson, Michelle Peckham, Megan Wright, BBSRC (Jun 2018), £150,443
Simon Walker, Royal Society (Jun 2018), £337,601
Tom Thirkell, N8 Agrifood (Jun 2018), £14,870
Stephen Muench with Glaxo SmithKline & UCB Celltech, BBSRC Industrial Partnership Award (Apr 2018), £480,225
Steve Clapcote, BBSRC (Apr 2018), £443,072
Helen Miller, Innovate UK (Apr 2018), £999,960
Elisabetta Groppelli, David Rowlands & Stanley Lemon (University of North Carolina), Medical Research Foundation Fellowship (Apr 2018), £293,494
Nikesh Patel, Medical Research Foundation fellowship (Apr 2018), £290,976
Graham Askew with colleagues in Hull and Liverpool, BBSRC (Apr 2018), £150,498
Andrew Macdonald, Neil Ranson & Richard Foster, Kidney Research UK (Apr 2018), £82,821
Jessica Kwok & Ralf Richter, Leverhulme Trust (Apr 2018), £298,273
Julie Aspden, Royal Society (Apr 2018), £20,000
Liz Duncan, Royal Society (Mar 2018), £14,602
Alex O'Neill & Ryan Seipke, BBSRC (Feb 2018), £45,489
Jim Deuchars, Royal Society (Feb 2018), £16,300
Stefan Kepinski & Netta Cohen, Leverhulme Trust (Feb 2018), £320,387
Lisa Collins, BBSRC (Feb 2018), £49,950
Alison Baker, BBSRC (Feb 2018), £30,000
Nikita Gamper, BBSRC (Feb 2018), £30,000
Lars Jeuken, BBSRC (Feb 2018), £30,000
Scott Bowen, Leducq Foundation Grant (Feb 2018), £28,470
Jessica Kwok and Ronaldo Ichiyama, International Spinal Research Trust (Feb 2018), £94,450
Alex O'Neill, Oxford Drug Design (Jan 2018), £86,098
Dave Lewis and Colleagues in South Africa, HEFCE Global Challenge Research (Jan 2018), £48,000
Sarah Calaghan, Ed White, John Colyer, Isuru Jayasinghe, BHF (Jan 2018), £128,308
Christine Foyer and Alison Baker, HEFCE GCRF Grant (Jan 2018), £71,158
Alison Baker, Yun Yung Gong and Lindsay Stringer and ICRISAT India, HEFCE GCRF Grant (Jan 2018), £27,000
Graham Askew, Simon Walker, BBSRC (Jan 2018), £699,781
Jennifer Tomlinson, Royal Society (Jan 2018), £512,801
Alison Dunn, NERC (Dec 2017), £18,000
Jennifer Tomlinson, Royal Society-Research Fellows Enhancement Award (Dec 2017), £94,681
Helen Miller, AB AGri Grant (Dec 2017), £73,600
Simon Walker, Royal Society Enhancement Award (Dec 2017), £10,000
Carrie Ferguson, Bryan Taylor, Harry Rossiter, The Physiological Society (Dec 2017), £7,392
Ralf Richter, Royal Society (Dec 2017), £6,000
Christine Foyer, British Council Newton Fund (Dec 2017), £49,840
Adrian Whitehouse and colleagues in School of Chemistry and University of Liverpool, MRC (Nov 2017), £622,319
Michelle Peckham, Neil Ransom, MRC (Nov 2017), £495,159
Dave Lewis, British Council India (Nov 2017), £22,540
Elton Zeqiraj, Royal Society (Nov 2017), £15,000
Hannah Dugdale, Royal Society (Nov 2017), £15,000
Shaunna Burke, Cancer Research UK Innovation Grant (Nov 2017), £20,000
Alex O'Neill and colleagues in Chemistry, BBSRC (Nov 2017), £431,865
Jessica Kwok, Wings for Life (Nov 2017), £87,365
Tom Bennett, BBSRC (Oct 2017), £523,679
Neil Ranson, Darren Tomlinson, BBSRC (Oct 2017), £494,318
Nikita Gamper, BBSRC (Oct 2017), £490,426
Amanda Bretman and colleagues from UEA, NERC (Oct 2017), £430,886
Juan Fontana, Rosetrees Trust consumables grant (Oct 2017), £22,500
Helen Miller, DSM Nutritional Products AG (Sep 2017), £69,988
Neil Ranson, Juan Fontana, Mark Harris, Michelle Peckham, Ralf Richter, Peter Stockley, Patricija Van Oosten-Hawle and colleagues in Engineering, FMH and MAPS, Wellcome Trust Equipment Call (Sep 2017), £418,000
Jamie Johnston, Physiological Society (Sep 2017), £10,000
Frank Sobott, Adrian Goldman, Mark Harris, Andrew Macdonald, Stephen Muench, Sheena Radford and colleagues in FMH and MAPS, Wellcome Trust Equipment Call (Aug 2017), £415,000